ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $238,740 | -25.7% | 8,885 | -1.4% | 0.01% | -27.3% |
| Q2 2023 | $321,297 | +33.3% | 9,010 | -5.0% | 0.01% | +10.0% |
| Q1 2023 | $240,995 | -37.4% | 9,488 | 0.0% | 0.01% | -47.4% |
| Q4 2022 | $384,833 | -99.9% | 9,488 | +1.5% | 0.02% | +26.7% |
| Q3 2022 | $309,018,000 | +108327.4% | 9,350 | +15.5% | 0.02% | +15.4% |
| Q2 2022 | $285,000 | -24.4% | 8,093 | -1.3% | 0.01% | -7.1% |
| Q1 2022 | $377,000 | -23.1% | 8,203 | +10.9% | 0.01% | -17.6% |
| Q4 2021 | $490,000 | +21.9% | 7,395 | +14.8% | 0.02% | +13.3% |
| Q3 2021 | $402,000 | -11.1% | 6,443 | +18.1% | 0.02% | -6.2% |
| Q2 2021 | $452,000 | +44.9% | 5,456 | +16.0% | 0.02% | +23.1% |
| Q1 2021 | $312,000 | – | 4,703 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |